ILM peeling may modify RNFL thickness

Article

Internal limiting membrane (ILM) peeling surgery causes significant modification of retinal nerve fibre layer (RNFL) thickness, according to researchers at the Ophthalmology Units of the University of Bologna and the Sant'Orsola-Malpighi Polyclinic.

Internal limiting membrane (ILM) peeling surgery causes significant modification of retinal nerve fibre layer (RNFL) thickness, according to researchers at the Ophthalmology Units of the University of Bologna and the Sant'Orsola-Malpighi Polyclinic.

The researchers conducted a single-centre, prospective, interventional consecutive case series of 30 eyes in 30 patients who had ILM peeling for idiopathic macular hole or epiretinal membrane. Prior to the surgery and at 1, 3 and 6 months post surgery the patients received a complete ophthalmic exam, fundus images were taken and spectral domain optical coherence tomography was performed. RNFL thickness was evaluated in the superotemporal, temporal, inferotemporal, inferonasal, nasal and superonasal sectors, as well as globally. Visual field testing was performed prior to the surgery and at the 6-month postoperative follow up.

One month after ILM peeling surgery there was a diffuse increase in RNFL thickness, but the nerve fibre layer had returned to preoperative values at the 3-month follow-up. However, at 6 months post-surgery, the RNFL thickness in the superotemporal, inferotemporal and temporal sectors was lower than basal values (P P P

The researchers found no correlation between the RNFL thickness and the patients' visual field indices.

According to the researchers, the increase in RNFL thickness seen 1 month postoperatively could have been caused by inflammatory responses. However, the reduction of RNFL thickness found in the temporal sectors at 6 months postoperatively could demonstrate that the ILM peeling caused damage to the RNFL.

The study was published in Retina. To view the abstract, click here.

Recent Videos
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
Paulo Antonio Silva, Associate Professor of Ophthalmology at Harvard Medical School
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
© 2024 MJH Life Sciences

All rights reserved.